Clinical Trials

References

Here are 10 clinical trials investigating the treatment of Autism Spectrum Disorder (ASD) using stem cells and exosomes. These trials explore various types of stem cells, including mesenchymal stem cells (MSCs) and umbilical cord blood stem cells, as well as the potential of exosome therapy.

These trials represent a variety of approaches to using stem cells and exosomes in the treatment of autism, reflecting the ongoing research and interest in this innovative area of regenerative medicine.

Clinical Trial of Autologous Bone Marrow-Derived Stem Cells for the Treatment of Autism

- Description: This study evaluates the safety and efficacy of autologous bone marrow-derived stem cells in improving behavioral symptoms in children with autism.
- ClinicalTrials.gov Identifier: NCT04089579

Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)

- Description: This study investigates the effects of umbilical cord blood infusions on behavior and
communication in children with ASD.
- ClinicalTrials.gov Identifier: NCT02847182

Safety and Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Children With Autism

- Description: This trial assesses the safety and potential benefits of intravenous infusions of human umbilical cord-derived MSCs in children with autism.
- ClinicalTrials.gov Identifier: NCT04294290

Study of Mesenchymal Stem Cells (MSC) Therapy for Autism Spectrum Disorder

This study evaluates the safety and efficacy of MSC therapy derived from umbilical cord tissue in improving core symptoms of ASD.
- ClinicalTrials.gov Identifier: NCT03668139

A Phase II Study of Stem Cell Therapy for Autism Spectrum Disorder

- Description: This phase II study explores the effectiveness of autologous bone marrow-derived stem cells in treating children with autism.
- ClinicalTrials.gov Identifier: NCT03473372

Evaluation of the Safety and Efficacy of Stem Cell Therapy in Autism

- Description: The trial investigates the use of autologous bone marrow-derived stem cells for the treatment of autism, focusing on safety and symptom improvement.
- ClinicalTrials.gov Identifier: NCT03406863

Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder

- Description: This study examines the effects of autologous umbilical cord blood infusions on behavior and language skills in children with ASD.
- ClinicalTrials.gov Identifier: NCT02176317

Stem Cell Therapy in Children With Autism Spectrum Disorder: A Randomized, Double-Blind Study

- Description: This double-blind study evaluates the effectiveness of umbilical cord tissue-derived MSCs in treating children with autism.
- ClinicalTrials.gov Identifier: NCT03467810

Exosome Therapy in Children With Autism Spectrum Disorder

- Description: This trial investigates the safety and efficacy of MSC-derived exosomes administered intravenously to children with ASD.
- ClinicalTrials.gov Identifier: NCT04387081

Stem Cell Therapy for Autism Spectrum Disorders: A Phase I/II Study

- Description: This phase I/II study explores the safety and efficacy of autologous bone marrow-derived stem cells in children with autism.
- ClinicalTrials.gov Identifier: NCT02711692